Core Viewpoint - The company has announced the completion and early termination of certain fundraising projects, reallocating surplus funds to enhance working capital for daily operations [1] Group 1: Project Completion - The company held its fourth board meeting on December 26, 2025, where it approved the completion of the "Zhengfan Baitai (Suzhou) Technology Co., Ltd. New Biopharmaceutical Core Equipment and Materials R&D Production Base Project," which has been completed and is ready for use [1] - The company also approved the early termination of the "Tongling Zhengfan Electronic Materials Co., Ltd. Special Gas Construction Project (Phase II) - Annual Production of 890 Tons of Advanced Electronic Materials and 300,000 Cubic Meters of Electronic Grade Mixed Gases Project," with some sub-projects already reaching the intended usable status [1] Group 2: Surplus Fund Allocation - As of December 23, 2025, the surplus funds from the Zhengfan Baitai project amounted to 32.69 million yuan, while the surplus from the Tongling Phase II project was 100.73 million yuan, totaling 133.42 million yuan [1] - The company plans to permanently allocate these surplus funds to enhance its working capital for daily production and operations, and will cancel the corresponding fundraising special accounts after the transfer [1]
正帆科技:拟将部分募投项目结项,13342.41万元节余资金拟用于补充流动资金